Basic information about inhibitors

IPAD-DB ID	C00380
Name	Huperzine A
Category	Natural compounds
2D Structure
3D Structure
Molecular Formula	C 1 5 H 1 8 N 2 O
Molecular Weight	242.32 g/mol
IUPAC Name	(13Z)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02, 7]trideca-2(7), 3, 11-trien-5-one
InChI	InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11, 16)12-4-5-14(18)17-13(12)7-10/h3-5, 8, 10H, 6-7, 16H2, 1-2H3, (H, 17, 18)/b11-3-
InChIKey	APLHEOBEIBHCHW-JYOAFUTRSA-N
Canonical SMILES	CC=C1C2CC(=CC1(C3=C(C2)NC(=O)C=C3)N)C
PubChem CID	5852186
DrugBank Accession Number	-
CAS Registry Number	-

Biological activity data

Ki	-
EC50	-
IC50	-
Inhibition	-
Toxicity	-
ROS(reactive oxygen species)	-
Metal Chelating	-
BBB(blood-brain barrier)	-
Target Protein	Acetylcholinesterase (AChE)
Effects	(1) Huperzine A can increase the levels of acetylcholine in the body, improve the functions of brain and nerve, and cause an improvement in cognitive function,
Research Models	-
Main Source	-
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)	242.32
Hac(Computed by SwissADME)	18
Volume(Computed by ADMETlab 2.0)	259.928
Density(Computed by ADMETlab 2.0)	0.932
nRing(Computed by ADMETlab 2.0)	3
MaxRing(Computed by ADMETlab 2.0)	12
nHet(Computed by ADMETlab 2.0)	3
fChar(Computed by ADMETlab 2.0)	0
nRig(Computed by ADMETlab 2.0)	17
Flexibility(Computed by ADMETlab 2.0)	0
Stero Centers(Computed by ADMETlab 2.0)	2
LogS(Computed by ADMETlab 2.0)	-2.339
LogD(Computed by ADMETlab 2.0)	2.661

ADMET properties

logP(Computed by ADMETlab 2.0)	2.038
TPSA(Computed by SwissADME)	58.88
Hbond Acceptor(Computed by SwissADME)	2
Hbond Donor(Computed by SwissADME)	2
Rotatable Bonds(Computed by SwissADME)

Pharmacokinetics

GI Absorption(Computed by SwissADME)	High
BBB(blood-brain barrier) Permeant(Computed by SwissADME)	Yes
P-gp Substrate(Computed by SwissADME)	Yes
CYP1A2 Inhibitor(Computed by SwissADME)	No
CYP2C19 Inhibitor(Computed by SwissADME)	No
CYP2C9 Inhibitor(Computed by SwissADME)	No
CYP2D6 Inhibitor(Computed by SwissADME)	No
CYP3A4 Inhibitor(Computed by SwissADME)	No
log Kp(Skin Permeation)(Computed by SwissADME)	-7.77

Druglikeness

Lipinski(Computed by SwissADME)	0
Ghose(Computed by SwissADME)	0
Veber(Computed by SwissADME)	0
Egan(Computed by SwissADME)	0
Muegge(Computed by SwissADME)	0
Bioavailability Score(Computed by SwissADME)	0.55